| News & Announcements | Preventive Coverage Update of Combined Chlamydia and Gonorrhea Testing for Medicare Advantage Members (Retroactively effective 01/01/2026) | | | | | | 3/23/2026 | | | |
| News & Announcements | Additional Services Eligible Through Telehealth for Medicare Advantage Members (Retroactively Effective 01/01/2026) | | | | | | 3/26/2026 | | | |
| Notifications | Musculoskeletal Services | MA00.047s | 3/2/2026 11:00 AM | 6/1/2026 | | | 3/2/2026 | Medical Necessity Criteria | | |
| Notifications | Level of Care for Elective Procedures (Hospital Inpatient to Hospital Outpatient Level of Care) | MA12.012 | 3/2/2026 12:00 PM | 6/1/2026 | | | 3/2/2026 | This is a New Policy. | | |
| Notifications | Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments | MA06.025s | 3/6/2026 10:00 AM | 6/5/2026 | | | 3/6/2026 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Notifications | Apheresis Therapy | MA06.001g | 3/10/2026 10:00 AM | 6/8/2026 | | | 3/10/2026 | Coverage and/or Reimbursement Position;Medical Necessity Criteria | | |
| Notifications | Site of Care for Elective Procedures [Hospital Outpatient Setting to Ambulatory Surgical Center (ASC)] | MA12.005 | 3/2/2026 3:00 PM | 6/1/2026 | | | 3/25/2026 | This is a New Policy. | 3/25/2026 | |
| New Policies | Multiple Procedure Payment Reduction (MPPR) Guidelines for Transvaginal and Transabdominal Ultrasounds | MA00.057 | 12/2/2025 2:00 PM | 3/2/2026 | | | 3/2/2026 | This is a New Policy. | | |
| New Policies | Reimbursement of Surgical Pathology Services for Prostate Biopsy | MA00.058 | 12/2/2025 2:00 PM | 3/2/2026 | | | 3/2/2026 | This is a New Policy. | | |
| New Policies | Reimbursement for Emergent Inpatient Admissions | MA00.059 | 2/3/2026 3:00 PM | 3/5/2026 | | | 3/5/2026 | This is a New Policy. | | |
| Updated Policies | Reimbursement for Certain Evaluation and Management (E/M) Services | MA00.049c | 12/2/2025 3:00 PM | 3/2/2026 | | | 3/2/2026 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Mirikizumab-mrkz (Omvoh®) for Intravenous Use | MA08.169a | 12/16/2025 9:00 AM | 3/16/2026 | | | 3/16/2026 | Medical Necessity Criteria | | |
| Updated Policies | Total Parenteral Nutrition (TPN) / Intradialytic Parenteral Nutrition (IDPN) | MA08.008h | 12/16/2025 3:00 PM | 3/16/2026 | | | 3/16/2026 | Medical Necessity Criteria | | |
| Updated Policies | Intravenous (IV) Iron Preparations | MA08.150a | 12/23/2025 9:00 AM | 3/23/2026 | | | 3/23/2026 | Medical Necessity Criteria | | |
| Updated Policies | Inebilizumab-cdon (Uplizna®) | MA08.126c | | 3/23/2026 | | | 3/23/2026 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Radiation Therapy Services (AmeriHealth) | MA09.020w | | 2/25/2026 | | | 3/23/2026 | Coverage and/or Reimbursement Position;Medical Necessity Criteria | | |
| Updated Policies | Interleukin-5 (IL-5) Antagonist (e.g., Cinqair®, Exdensur, Nucala®) and IL-5 Receptor Antagonist (e.g., Fasenra®) | MA08.024n | | 3/23/2026 | | | 3/23/2026 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Luspatercept–aamt (Reblozyl®) | MA08.110e | | 3/23/2026 | | | 3/23/2026 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Omalizumab (Xolair®) and related biosimilars | MA08.025i | | 3/23/2026 | | | 3/23/2026 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Nivolumab (Opdivo®), Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig™) | MA08.120g | | 3/23/2026 | | | 3/23/2026 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Dermabrasion for Rhinophyma, Septoplasty, Rhinoplasty, and Septorhinoplasty | MA11.099f | 12/26/2025 9:00 AM | 3/30/2026 | | | 3/30/2026 | Coverage and/or Reimbursement Position;Medical Coding | 3/30/2026 | |
| Updated Policies | Medicare Part B vs. Part D Crossover Drugs | MA08.007au | | 3/30/2026 | | | 3/30/2026 | Coverage and/or Reimbursement Position | | |
| Reissue Policies | Computer-Assisted Musculoskeletal Surgical Navigational Orthopedic Procedure | MA11.088c | | 1/1/2024 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions | MA11.087c | | 1/1/2024 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint Management | MA01.008d | | 10/1/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Percutaneous Intradiscal Annuloplasty (IDET/PIRFT) | MA11.025 | | 1/1/2024 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Manipulation Under Anesthesia | MA11.091b | | 1/1/2024 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Nivolumab and relatlimab-rmbw (Opdualag™) for intravenous use | MA08.152d | | 6/16/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Application and Removal of Tattoos | MA11.072 | | 1/1/2015 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Heating Pads and Heat Lamps | MA05.029d | | 4/21/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Canes and Crutches | MA05.052c | | 4/21/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Orthopedic Footwear | MA05.012c | | 1/1/2024 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Autonomic Nervous System Testing | MA07.027h | | 6/16/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Chemical Peels | MA11.103c | | 12/29/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Nerve Fiber Density Testing | MA06.023c | | 1/1/2024 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Tracheostomy Care Supplies | MA05.034a | | 5/6/2024 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Commode Chairs | MA05.036c | | 4/21/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Walkers | MA05.037b | | 10/1/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Surgical Treatment of Nails | MA11.036e | | 4/21/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Ultraviolet Light Therapy for the Treatment of Dermatological Conditions | MA07.002i | | 10/1/2024 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Procedures for the Treatment of Acne | MA11.109a | | 10/1/2016 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Photodynamic Therapy (PDT) Using Levulan® Kerastick® or Ameluz® (Aminolevulinic Acid HCl [ALA]) | MA07.056f | | 1/1/2026 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer | MA06.036 | | 1/27/2025 | 3/4/2026 | | 3/4/2026 | | | |
| Reissue Policies | Agalsidase beta (Fabrazyme) and pegunigalsidase alfa-iwxj (Elfabrio) | MA08.033d | | 9/9/2024 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Magnetic Resonance Imaging (MRI)-Guided Focused Ultrasound Ablation | MA09.021f | | 1/1/2025 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Labiaplasty | MA11.067e | | 2/24/2025 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Mentoplasty or Genioplasty | MA11.080c | | 10/1/2025 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Nusinersen (Spinraza®) | MA08.086d | | 1/1/2024 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Photodynamic Therapy Using Verteporfin (Visudyne®) | MA07.003f | | 2/2/2026 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) | MA07.004j | | 10/1/2025 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Rhytidectomy and/or Cervicoplasty With or Without Liposuction and/or Platysmaplasty | MA11.075b | | 1/1/2025 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Positron Emission Mammography (PEM) | MA09.015 | | 1/1/2024 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Surgery for Gynecomastia | MA11.110a | | 12/19/2022 | 3/4/2026 | | 3/5/2026 | | | |
| Reissue Policies | Pulse Oximetry Device in the Home Setting | MA05.042a | | 1/1/2024 | 3/18/2026 | | 3/18/2026 | | | |
| Reissue Policies | Drug-Eluting Beads and Bland Embolization for the Treatment of Hepatic Malignancies | MA07.041c | | 10/1/2024 | 10/29/2025 | | 3/27/2026 | | 3/27/2026 | |
| Coding Update | Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD) | MA11.055g | | 1/1/2026 | | | 3/5/2026 | | 3/5/2026 | |
| Coding Update | External Infusion Pumps | MA05.060f | | 3/20/2026 | | | 3/20/2026 | | | |